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that the incidence of candidemia was 0.56 per 1,000 
hospital admissions per year and there was a statistically 
signifi cant increase in the incidence of candidemia caused 
by non- Candida albicans Candida species [7]. 
 Although in recent years  Candida albicans is respon-
sible for more than half of the cases of candidemia, the ratio 
of infections due to non- Candida albicans Candida species 
has gradually increased. Some possible risk factors, such 
as fl uconazole prophylaxis, underlying hematological 
malignancies or patient ’ s age were identifi ed in previous 
studies. However, there are still limited data about factors 
associated with infections due to non- Candida  albicans 
Candida species [2,6,8]. 
 Several non -Candida albicans Candida species are 
resistant to or have decreased susceptibility to fl uconazole 
 in vitro , although the clinical relevance of this information is 
not well defi ned. On the other hand, as fl uconazole is gener-
ally effective against  C. albicans, it is a safe and inexpensive 
treatment of choice [9]. Determining risk factors associated 
with BSIs caused by  C. albicans and non- Candida albicans 
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 This study was planned to determine the risk factors of candidemia, and the most com-
mon  Candida species causing bloodstream infections. A case-control study which 
included adult patients was conducted over a 1-year period at tertiary-care educational 
hospitals in Turkey. A total of 83 candidemia episodes were identifi ed during the study 
period.  Candida albicans was the most common species recovered (45.8%) followed by 
 Candida tropicalis (24.1%)  Candida parapsilosis (14.5%) and  Candida glabrata which 
was isolated from only four (4.8%) patients. Presence of a urethral catheter (odds ratio 
[OR] 2.38; 95% confi dence interval [CI] 1.09 – 5.19;  P  0.02), previous use of anti-
biotics (OR 2.61; 95% CI 1.05 – 6.46;  P   0.03), RBC transfusions (OR 2.14; 95% CI 
1.16 – 3.94;  P   0.01) and parenteral nutrition (OR 4.44; 95% CI 2.43 – 8.11;  P   0.01) 
were found as independent risk factors for candidemia. TPN (Total Parenteral Nutrition) 
was an independent risk factor for both C. albicans and non- Candida albicans  Candida 
species ( P   0.001). Most of the risk factors were invasive procedures and former medi-
cations. We conclude that a great number of candidemia cases are preventable by means 
of reduction of unnecessary invasive procedures and the use of antimicrobials.  
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 Introduction 
 In recent years,  Candida species have emerged as major 
causes of infections among patients with serious underlying 
diseases such as hematological malignancies or critically 
ill patients hospitalized in Intensive Care Units (ICUs). 
Those infections have raised concerns as a result of high 
mortality rates and medical costs [1,2].  Candida spp. are 
the fourth leading cause of nosocomial bloodstream infec-
tions (BSIs) in the United States (US) and sixth in Turkey 
[3 – 5]. The incidence of candidemia per 1,000 admissions 
varies between 0.17 (in general hospitals) and 20 (in ICU 
patients) in European countries [6]. It ranges from 6 – 24 
per 100,000 population per year in US [2]. In a study con-
ducted between 2000 and 2003 in our country, it was found 
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Candida species, which was one of the aims of our study, 
can provide guidance in deciding on empirical anticandidal 
therapy. 
 In Turkey, there are limited reports documenting the spec-
trum of yeasts responsible for candidemia and risk factors, 
therefore we conducted an observational, multi-center, 
case-control study to investigate causative agents and risk 
factors of candidemia in adult patients at six tertiary-care 
educational hospitals.  
 Methods 
 Study design and patient selection 
 An observational, prospective, case-control study was con-
ducted from February 2008 to the end of January 2009 with 
the aim of analyzing  Candida species causing candidemia 
and their risk factors in six Turkish tertiary-care educational 
hospitals. The study included patients older than 18 years 
of age with  Candida BSIs, the latter being defi ned as isola-
tion of any species of  Candida in at least one blood culture 
of patients who presented with clinical signs or symptoms 
of infection [10]. We randomly selected at least two control 
patients for each case who were matched according to the 
age groups hospitalized in the same hospital in the same 
period with no signs and symptoms of candidemia and with 
negative blood cultures for  Candida spp. 
 Data collection 
 Study team members from each hospital collected demo-
graphic and clinical data by reviewing patients ’ medical 
reports. Since the study was an observational noninterven-
tional investigation, all decisions regarding patient manage-
ment including the diagnostic tests and antifungal treatment 
were made by the patients ’ physicians and not by the 
research team members. The case group data used for risk 
factor analyses were collected up to the time of the devel-
opment of candidemia and the data for controls were 
collected up to the same day. Risk factors for the last 
30 days prior to onset of candidemia were assessed. The 
parameters collected for each case and controls included 
age, gender, length of stay (LOS) in the hospital. In addi-
tion, we considered the presence of predisposing factors 
such as diabetes mellitus, chronic renal failure, chronic 
obstructive pulmonary disease (COPD), malignancy, organ 
transplantation, surgical procedures, presence of central 
venous (CVC) or urethral catheters, mechanical ventila-
tion, red blood cell (RBC) transfusion, administration of 
total parenteral nutrition (TPN), anticancer chemotherapy, 
steroids, antibiotics and antifungals. The Eastern Coopera-
tive Oncology Group (ECOG) Performance Status was 
used to assess the patient ’ s daily living abilities [11]. 
 Identifi cation of species 
 Blood cultures were processed at each of the hospitals 
participating in the study by an automated system (Bactec, 
Becton Dickinson, USA) and isolates were transferred to 
blood agar and Sabouraud dextrose agar. After the germ-
tube test, yeasts were identifi ed according to their morphol-
ogy on cornmeal Tween 80 agar, colour on CHROMagar 
 Candida (CHROMagar, France) and biochemical tests 
using API 20C AUX System (bioM é rieux, France). 
 Statistical analyses 
 Categorical variables were evaluated using the chi-square 
and 2-tailed Fisher ’ s exact tests. For continuous variables 
the t-test was used. Variables that were found as signifi cant 
( P   0.05) in these tests were considered as candidates for 
multivariate analysis. Multivariable, backwards stepwise, 
logistic regression analyses were built to identify indepen-
dent risk factors for candidemia. All statistical analyses were 
performed with Statistical Package for the Social Sciences 
(SPSS, Version 15.0, Chicago, Il, USA) and CDC software 
EPI INFO (version 6.0, Atlanta, GA, USA). 
 Results 
 During the study period, 83 candidemia episodes in 83 
patients were identifi ed, of which 47 (56.6%) cases involved 
males with a mean age of 55.04   17.04 (18 – 84) years 
as compared to 55.83  16.56 (18 – 90) years of age in the 
control group. Thirty-three of the patients (39.7%) were 
hospitalized in intensive care units (ICUs), 26 (31.3%) in 
surgical wards and 24 (29%) were in medical wards. The 
median time interval between the initial hospitalization and 
the diagnosis of candidemia was 18 (1 – 191) days.  
 Distribution of species causing candidemia 
 C. albicans was recovered from 38 (45.8%) of the patients, 
whereas non- Candida albicans Candida species were iso-
lated from 45 (54.2%). Among the latter yeasts,  Candida 
tropicalis was the most frequently isolated, followed by 
 Candida parapsilosis ,  Candida glabrata and  Candida 
kefyr . Distribution of  Candida species isolated from 
patients with candidemia is given in Table 1. 
 Risk factors associated with candidemia 
 Risk factors identifi ed in univariate analyses associated 
with the occurrence of candidemia were length of hospital-
ization, high ECOG scores (3 or more), presence and dura-
tion of urethral and central venous catheters (CVC), central 
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antibiotic and antifungal therapy, RBC transfusions and 
total parenteral nutrition (TPN). The patients ’ characteris-
tics and risk factors for candidemia are given in Table 2. 
 In multivariate analysis, the presence of a urethral cath-
eter, previous use of antibiotics, transfusion of RBC and 
parenteral nutrition were found as independent risk factors 
associated with candidemia as presented in Table 3. 
 Risk factors for candidemia due to C. albicans and 
non-Candida albicans Candida species 
 When the risk factors associated with candidemia caused 
by  C. albicans were evaluated, it was found that signifi cant 
differences existed between the clinically ill patients and 
the controls with respect to the following factors; previous 
use of broad spectrum antibiotics and any antifungal agent, 
history of at least one of the following surgical procedures: 
central nervous system, thoracic or abdominal surgery, 
transfusion of red blood cells (RBC), high ECOG scores 
(more than 2), neutropenia, presence of indwelling cathe-
ters, endotracheal intubation, mechanical ventilation and 
TPN. Among these risk factors we found no signifi cant 
differences between the patients and controls in cases 
involving non- Candida albicans Candida species relative 
to surgical procedures, neutropenia, intubation and mechan-
ical ventilation. Results of univariate analyses are given in 
Table 4. 
 In multivariate analysis, TPN, neutropenia and surgical 
procedures mentioned above were identifi ed as independent 
risk factors for  C. albicans infections, whereas TPN, previ-
ous usage of antibiotics and presence of urethral catheters 
were found to be important in non- Candida albicans 
candidemia cases. Details are presented in Tables 5 and 6. 
 Discussion 
 Distribution of species causing candidemia 
 In the present study we identifi ed 83 candidemia episodes 
in 83 patients in which  C. albicans was the most common 
isolate (45.8%) recovered from clinical specimens. However 
non- Candida albicans Candida species were associated in 
a higher ratio (54.2%) than  C. albicans when they were 
 considered together. Among non- Candida albicans Candida 
 Table 1  Candida species isolated from patients with candidemia.  
 Candida species  n (%)
 Candida albicans 38 (45.8)
 Candida tropicalis 20 (24.1)
 Candida parapsilosis 12 (14.5)
 Candida glabrata 4 (4.8)
 Candida kefyr 3 (3.6)
Others 6 (7.2)
 Table 2 Patient characteristics and risk factors for candidemia.  
Patient characteristics 
and risk factors
Cases ( n  83)
 n (%)
Controls ( n  221)
 n (%)  P values
Gender
 Male
47 (56.6) 120 (54.3) 0.716
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 species,  C. tropicalis was the most frequently recovered 
pathogen followed by  C. parapsilosis ,  C. glabrata and  C. 
kefyr . Although the frequency of  Candida species varies 
according to the geographical setting, a decreasing trend 
in the isolation of  C. albicans has been noted worldwide 
[2,6,12]. 
 In the ARTEMIS DISK Surveillance program conducted 
between 1997 and 2003, increased rates of infections caused 
by  C. tropicalis and  C. parapsilosis were observed although 
there were no signifi cant changes in the isolation rates of 
 C. glabrata and C. krusei [9]. In the European Confedera-
tion of Medical Mycology (ECMM) survey, incidence rates 
were 14% for  C. glabrata and  C. parapsilosis infections, 
7% for  C. tropicalis and 2% for  C. krusei [13,14]. 
 In our study, the distribution of  Candida species was 
generally similar to reports from European countries. An 
exception is the frequency of  C. tropicalis which was the 
second most common species isolated from our cases. 
C. tropicalis is an important pathogen in patients with 
hematological malignancies and in the US, the frequency 
of this yeast in clinical cases apparently decreased as a 
result of the use of fl uconazole prophylaxis. However, in 
other countries, especially in Latin America and Asia-Pasifi c 
region,  C. tropicalis is more common [2,6,15,16]. Xess 
 et al. , reported that  C. tropicalis was the most frequently 
isolated species during a 5-year study period in North India 
[17]. Similarly, in a retrospective investigation conducted 
in one of our study hospitals between 2000 and 2003, 
C. tropicalis was the most common non- Candida albicans 
Candida species (20.2%) identifi ed, followed by  C. parap-
silosis (12.5%),  C. guilliermondii (3.8 %) and  C. glabrata 
(3.8%) [7]. This frequent isolation of  C. tropicalis in our 
study population could be explained, in part, by the lower 
ratio of patients receiving fl uconazole prophylaxis and geo-
graphical features [2,6,7].  Candida glabrata which is one 
of the fl uconazole resistant non- Candida albicans  Candida 
species was responsible for only four candidemia episodes 
in our patients. This species has emerged as an important 
fungal pathogen in the US accounting for 20 – 24% of all 
 Candida BSIs [2]. In contrast, in most surveys from Euro-
pean countries and from Latin America, lower frequencies 
of  C. glabrata infections were reported [6,15,18]. In two 
reports from our country,  C. glabrata was isolated from 
5% and 8.8% of patients hospitalized in tertiary care hos-
pitals [19,20]. The reasons for these different frequencies 
in different countries are not clear but may include expo-
sure to azoles, patients ’ age, geographical features and the 
sensitivity of blood culture media used in the study 
[2,6,8].  
 Risk factors associated with candidemia 
 Risk factors involved in candidemia can be divided into (i) 
host-related factors such as chronic renal failure, diabetes 
mellitus, trauma or other immunocompromising conditions 
and (ii) healthcare-related factors such as hospitalization 
 Table 3  Multivariate logistic regression analysis of independent risk 
factors for candidemia.  
Variables  P OR 95% CI
Urethral catheterization 0.02 2.38 1.09 – 5.19
Previous use of antibiotics 0.03 2.61 1.05 – 6.46
RBC transfusion 0.01 2.14 1.16 – 3.94
TPN   0.001 4.44 2.43 – 8.11
 OR: Odds Ratio; CI: Confi dence interval. 
 Table 4  Risk factors for candidemia due to  Candida albicans and non- Candida albicans  Candida spp. 
Risk factors
Albicans Candidemia ( n  38)
Controls
( n  221)
Non- Candida albicans 






P values  n (%)
Antibiotic use 33 (86.8)  0.04 158 (71.5)  0.001 43 (95.6)
Combination antibiotherapy (more than one) 27 (81.8)  0.0001 69 (43.7)  0.0001 69 (43.7)
Antifungal use 7 (18.4)  0.02 16 (7.2)  0.02 8 (17.8)
Major surgery 23 (60.5)  0.001 74 (33.4) 0.160 20 (44.4)
RBC transfusion 30 (78.9)  0.0001 102 (46.1)  0.01 30 (76.7)
ECOG Score (3 or more) 35 (92.1)  0.004 
(0.002) * * 
154 (69.6)  0.008 
(0.005) * * 
40 (88.8)
Neutropenia 6 (15.7)  0.02 11 (4.9) 0.643 3 (6.7)
Urethral catheter 31 (81.6)  0.01 133 (60.2)  0.0001 41 (91.1)
Central venous catheter 27 (71.1)  0.0001 83 (37.6)  0.0001 30 (66.7)
Intubation 23 (60.5)  0.02 91 (41.2) 0.884 18 (40.0)
Mechanical ventilation 23 (60.5)  0.01 85 (38.5) 0.714 16 (35.6)
Total parenteral nutrition 23 (60.5)  0.0001 42 (19.0)  0.0001 26 (57.8)
 * Fisher ’ s Exact Test.
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in the ICU, presence of CVCs, parenteral nutrition, antibi-
otic therapy, antifungal prophylaxis or surgical procedures 
[1]. In our patients, presence of urethral catheterization, 
previous use of antibiotics, RBC transfusions and TPN 
were identifi ed as independent risk factors of candidemia. 
However, unlike other studies in the literature, we did not 
fi nd length of hospitalization, CVC use, colonization with 
 Candida spp., hemodialysis, antifungal prophylaxis, 
mechanical ventilation, neutropenia or trauma as indepen-
dent risk factors [4,21 – 23]. Besides previously described 
host-related risk factors such as chronic underlying dis-
eases or immunocompromising conditions, we found no 
statistically signifi cant differences with respect to underly-
ing patient conditions between cases and controls [1,22]. 
It is interesting that use of CVCs was not found to be an 
independent risk factor in our study. We concluded that risk 
factors associated with candidemia could be related to the 
causative agents. In our study  C. albicans was the most 
common pathogen followed by  C. tropicalis .  Candida 
parapsilosis known as an agent of catheter-related fungemia 
was not common (14.5 %) and moreover, 60.3 % of our 
patients were hospitalized out of the ICU where CVCs are 
infrequently used.  
 Risk factors for candidemia due to C. albicans 
and non-Candida albicans species 
 When we performed multivariate analyses of risk factors 
for BSIs caused by  C. albicans and non- Candida albicans 
Candida species, TPN was an independent risk factor for 
candidemia caused these yeasts ( P   0.001). Additionally, 
an increased risk of  C. albicans BSIs was independently 
associated with neutropenia ( P  0.001) and surgical proce-
dures ( P  0.04) whereas previous antibiotic use ( P  0.03) 
and urethral catheterization ( P  0.03) were associated 
with an increased risk of developing non- Candida albicans 
 Candida candidemia. However some risk factors such as 
neutropenia and usage of antifungal drugs were rare in our 
study population. For that reason we were not confi dent to 
evaluate them as statistically signifi cant or not. 
 In a 5-year review of fungemia in Thailand, authors 
found that former bacteremia and presence of fungal colo-
nization were signifi cantly more common in patients with 
 C. albicans candidemia than those with non- Candida albi-
cans Candida candidemia [16]. In a prospective study 
performed in the ICU of a tertiary care hospital in Athens, 
the authors noted that administration of glucocorticoids, 
presence of CVCs and candiduria were independent risk 
factors with respect to candidemia caused by non- Candida 
albicans Candida species [24]. Chow  et al . reported that 
ICU patients having major surgical operations, gastrointes-
tinal procedures, enteric bacteremia, duration of TPN, 
number of hemodialysis days and RBC transfusions were 
associated with non -Candida albicans Candida candi-
demia [25]. For  C. albicans candidemia major surgery, 
enteric bacteremia, TPN duration and number of hemodi-
alysis days were independent risk factors in this study. 
In a prospective nationwide study reported from Australia, 
former exposure of antifungal drugs, gastrointestinal surgical 
procedures, increasing age and intravenous drug use were 
found to be associated with non- Candida albicans Candida 
candidiemia. Most common non- Candida albicans Candida 
species isolated in this study was  C. glabrata and this could 
be an explanation for risk factor about age [26]. 
 There are numerous studies investigating epidemiology 
and risk factors of candidemia in the English literature. 
However, most of them have been conducted in ICUs or 
hematology/oncology units and patients involved in these 
studies had some specifi c underlying conditions such as 
hematological or solid malignancies. Some of these studies 
included patients with only candidemia and analyses of 
risk factors or prognostic indicators were conducted with-
out control groups. For these reasons, results from these 
studies could be different in terms of risk factors. In our 
study we selected at least two control patients for each 
cases hospitalized in the same hospital ward in order to 
compare risk factors for candidemia. To our knowledge 
this is the fi rst case-control and multicenter study investi-
gating the epidemiology and risk factors of candidemia 
from Turkey. 
 Our study has some limitations. Possible predisposing 
conditions such as hemopoietic stem cell or solid organ 
transplantation, malignancy, trauma, intravenous drug 
abuse and renal failure were rare and these factors were 
not found to be independently related to candidemia despite 
the fact that they had been defi ned in previous studies. 
Additionally, we could not investigate the distribution of 
 Candida species in these specifi c conditions. Furthermore, 
we did not perform long-term follow up investigations 
of the patients after diagnosis of candidemia. Therefore 
 Table 5 Multivariate logistic regression analysis of independent risk 
factors for  Candida albican s candidemia.  
Variables  P OR 95% CI
TPN   0.001 5.76 2.46 – 13.52
Neutropenia 0.001 18.02 3.30 – 98.33
Major surgery 0.04 2.49 1.09 – 5.97
 Table 6  Multivariate logistic regression analysis of independent risk 
factors for non- Candida albicans candidemia.  
Variables  P OR 95% CI
TPN   0.001 3.98 1.93 – 8.20
Previous antibiotic use 0.03 5.04 1.13 – 22.47
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we cannot provide conclusions about mortality rates of  dif-
ferent  Candida species and risk factors affecting mortality. 
 We observed that the most common cause of candi-
demia was  C. albicans in our patient group. Non- Candida 
albicans  Candida species were more frequent etiologic 
agents than  C. albicans when they were considered together. 
The most common non- Candida albicans Candida species 
was  C. tropicalis . Additionally species known to be more 
resistant to antifungal agents such as  C. glabrata were rare. 
Important risk factors for candidemia were invasive proce-
dures and therapeutic interventions such as urethral cath-
eterization, parenteral nutrition, transfusion of RBC and 
usage of antimicrobial agents. We conclude that a great 
number of candidemias are preventable infections by reduc-
ing unnecessary invasive procedures or antimicrobials. 
However, further prospective studies with greater number 
of patients belonging to different risk groups should be 
planned in order to investigate the factors associated with 
infections caused by each  Candida species. 
 Declaration of interest: The authors report no confl icts of 
interest. The authors alone are responsible for the content 
and writing of the paper. 
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